Endovascular Therapy for Low NIHSS Ischemic Strokes (ENDOLOW)
STUDY OVERVIEW
This study conducted by Emory University School of Medicine aims to investigate whether patients with cerebral ischemia due to proximal large vessel occlusions (LVO) and low baseline NIHSS scores (0-5) would benefit from immediate mechanical thrombectomy (iMT) compared to initial medical management (iMM) in terms of 90-day clinical outcomes. Currently, these patients often do not undergo immediate vessel imaging despite the potential for clinical decline or underappreciated impairments related to their mild strokes, and this study seeks to address this gap in understanding.
STUDY GOALS
The goal of this study is to assess whether patients presenting with cerebral ischemia due to proximal large vessel occlusions (LVO) and low baseline NIHSS scores (0-5) experience better 90-day clinical outcomes with immediate mechanical thrombectomy (iMT) compared to initial medical management (iMM).
LOCATION
El Paso, Texas: Texas Tech Health Sciences Center at El Paso
INCLUSION CRITERIA
Age 18 or older
Clinical diagnosis of acute ischemic stroke with NIHSS score 0-5 and objective neurological deficit
Eligible for intravenous rt-PA treatment within 4.5 hours of symptom onset
Proximal intracranial artery occlusion confirmed by imaging, including complete occlusion of intracranial ICA, M1, or "M1-like" M2 vessel occlusion
exclusion criteria
NIHSS score ≥6
Evidence of intracranial hemorrhage or signs of futile recanalization on baseline imaging
High suspicion of intracranial arterial disease
Premorbid disability (mRS ≥3)
Inability to randomize within 8 hours of last known well
Baseline blood glucose <50 mg/dL or >400 mg/dL
Known coagulation disorders or renal failure
Suspected bacterial endocarditis or septic embolus
Conditions hindering endovascular procedure or posing significant risk to the subject
Participation in another investigational treatment study in the past 30 days
Intubation and mechanical ventilation before study enrollment
History of substance use or dependence affecting study adherence
Investigator's lack of equipoise towards treatment options
Known pregnancy or incarceration
Acute symptomatic COVID-19 infection
For more information, visit ClinicalTrials.gov.